BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28502558)

  • 1. Identification of candidate biomarkers that involved in the epigenetic transcriptional regulation for detection gastric cancer by iTRAQ based quantitative proteomic analysis.
    Jiang Z; Sun X; Zhang Q; Ji X; Yu Q; Huang T; Chen D; Chen H; Mei X; Wang L; He L; Fang J; Hou L; Wang L
    Clin Chim Acta; 2017 Aug; 471():29-37. PubMed ID: 28502558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomic analysis reveals that proteins required for fatty acid metabolism may serve as diagnostic markers for gastric cancer.
    Jiang Z; Shen H; Tang B; Yu Q; Ji X; Wang L
    Clin Chim Acta; 2017 Jan; 464():148-154. PubMed ID: 27884752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of metastasis associated 1 family member 2 (MTA2) in gastric cancer and its relationship with transcription factor Sp1].
    Zhou CF; Ji J; Yuan F; Yu YY; Liu BY; Zhang J; Zhu ZG
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):592-5. PubMed ID: 23158992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1.
    Zhou C; Ji J; Cai Q; Shi M; Chen X; Yu Y; Liu B; Zhu Z; Zhang J
    Mol Cancer; 2013 Sep; 12(1):102. PubMed ID: 24010737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer.
    Jiang Z; Zhang C; Gan L; Jia Y; Xiong Y; Chen Y; Wang Z; Wang L; Luo H; Li J; Zhu R; Ji X; Yu Q; Wang L
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800038. PubMed ID: 30485682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
    Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
    J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA SNHG5 suppresses gastric cancer progression by trapping MTA2 in the cytosol.
    Zhao L; Guo H; Zhou B; Feng J; Li Y; Han T; Liu L; Li L; Zhang S; Liu Y; Shi J; Zheng D
    Oncogene; 2016 Nov; 35(44):5770-5780. PubMed ID: 27065326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTA2 expression is a novel prognostic marker for pancreatic ductal adenocarcinoma.
    Chen DW; Fan YF; Li J; Jiang XX
    Tumour Biol; 2013 Jun; 34(3):1553-7. PubMed ID: 23400716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTA2 enhances colony formation and tumor growth of gastric cancer cells through IL-11.
    Zhou C; Ji J; Cai Q; Shi M; Chen X; Yu Y; Zhu Z; Zhang J
    BMC Cancer; 2015 May; 15():343. PubMed ID: 25929737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification and characterization of the human MTA2-RBBP7 complex.
    Brasen C; Dorosz J; Wiuf A; Boesen T; Mirza O; Gajhede M
    Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):531-538. PubMed ID: 28179136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of PGLS as a metabolic target for early screening and prognostic monitoring of gastric cancer.
    Yuan X; Xiao Y; Luo Y; Wei C; Wang J; Huang J; Liao W; Song S; Jiang Z
    J Clin Lab Anal; 2022 Feb; 36(2):e24189. PubMed ID: 34953081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of MTA2 in non-small cell lung cancer].
    Wang S; Qi Y; Zhang J; Zhang Q; Li H; Qiu X
    Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):777-80. PubMed ID: 20704817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of histone deacetylase 1 in gastric cancer tissues.
    Choi JH; Kwon HJ; Yoon BI; Kim JH; Han SU; Joo HJ; Kim DY
    Jpn J Cancer Res; 2001 Dec; 92(12):1300-4. PubMed ID: 11749695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional validation of caldesmon as a potential gastric cancer metastasis-associated protein.
    Hou Q; Tan HT; Lim KH; Lim TK; Khoo A; Tan IB; Yeoh KG; Chung MC
    J Proteome Res; 2013 Feb; 12(2):980-90. PubMed ID: 23265641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of histone deacetylase 1 inhibits metastatic abilities of gastric cancer cells by regulating the miR-34a/CD44 pathway.
    Lin L; Jiang H; Huang M; Hou X; Sun X; Jiang X; Dong X; Sun X; Zhou B; Qiao H
    Oncol Rep; 2015 Aug; 34(2):663-72. PubMed ID: 26035691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MTA2 gene in ovarian epithelial cancer and its clinical implication.
    Ji Y; Zhang P; Lu Y; Ma D
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):359-62. PubMed ID: 16961294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics-Based Identification and Analysis of Proteins Associated with Helicobacter pylori in Gastric Cancer.
    Zhou J; Wang W; Xie Y; Zhao Y; Chen X; Xu W; Wang Y; Guan Z
    PLoS One; 2016; 11(1):e0146521. PubMed ID: 26745502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of metastasis-associated protein 2 is associated with hepatocellular carcinoma size and differentiation.
    Lee H; Ryu SH; Hong SS; Seo DD; Min HJ; Jang MK; Kwon HJ; Yu E; Chung YH; Kim KW
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1445-50. PubMed ID: 19702911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hopeful anticancer role of oleuropein in breast cancer through histone deacetylase modulation.
    Mansouri N; Alivand MR; Bayat S; Khaniani MS; Derakhshan SM
    J Cell Biochem; 2019 Oct; 120(10):17042-17049. PubMed ID: 31119806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.